We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Aqua Bty Reg S | LSE:ABTX | London | Ordinary Share | COM SHS USD0.001 (REG S) |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 12.50 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 12.50 | GBX |
Aqua Bounty (ABTX) Share Charts1 Year Aqua Bounty Chart |
|
1 Month Aqua Bounty Chart |
Intraday Aqua Bounty Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 07/4/2020 | 20:51 | Aqua Bounty Technologies Inc (could well be a CRACKER) | 630 |
| 23/11/2011 | 13:28 | Aqua Bty Reg S with Charts & News | 29 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 31/5/2013 18:43 by goz1986 Good price movement...... |
Posted at 27/3/2013 21:38 by xcap LUFCS, thanks for postingexcellent read and good PR for ABTX |
Posted at 26/3/2013 20:22 by xcap Lufcs/gozcare to put any revenue figures on the sale of the salmon eggs and how big the market could be for ABTX |
Posted at 12/3/2013 13:54 by lufc5 6 weeks this Friday. I would expect positive news/rns shortly after.Most comments/concerns are the fact that it looks like it won't be labelled as GM, so nobody will know the difference from normally farmed salmon and Aqua Advantage salmon. Wild salmon or organic salmon will be a choice but, at a premium price,and the demand for those will further increase the price difference and make farmed salmon look like a bargain. The fact that alot of yanks will eat copious amounts of processed food, food pumped full of all manor of kak, takeaways/junk food...... Kinda makes one laugh really. The two month extension was merely a "well, we gave you all plenty of time to file your various complaints/concerns, and none have proven to be valid" blah blah.... Should take off big style once formally approved.....then the world wide roll out over time. Some even forget that they have other species of Aqua Advantage seafood too. Long and strong. |
Posted at 16/2/2013 16:19 by xcap all good points chaps.if share price drops further I'll be buying Captain Kirk will have to pay a decent price now for a take out imho whatever the outcome. He's confirmed that he is content that the bio-technology is valid, clearly works and is safe, otherwise why buy into ABTX. If refused (hopefully an unlikely outcome) he may take the company out and take the technology to a country(s) that will approve, for example the African nations and come out smelling of roses as a commercial philanthropist (obvioulsy won't being doing it without profit) |
Posted at 15/1/2013 16:11 by lufc5 The first GM animal could help feed the worldEver since dwarfs and Siamese twins have been paraded as circus entertainment, we have been fascinated by so-called freaks of nature. But only now are we starting to understand the genetic causes. The first sequencing of the human genome took ten years, cost $3bn and was completed in 2003. Since then there has been an extraordinary advance in our ability to sequence the genome of living things, from the human body down to the humblest bacteria. All over the world biotechnologists are mapping genomes, the recipe for life. Armed with this knowledge, it is possible to alter the recipe through genetic manipulation, and today genetically modified crops are grown in over 40 countries. Take this example... Just before Christmas I spotted one of the most significant announcements of 2012, from Aqua Bounty Technology Inc (ABTX), a US company that has its shares traded on AIM. The US Food and Drug Administration has indicated its inclination to approve Aqua Bounty's AquAdvantage Salmon, having found that they are safe to eat and do not pose a threat to the environment. These salmon are created by inserting the growth hormone gene from the Chinook salmon into Atlantic salmon eggs, which allows them to reach market size in half the time of conventional Atlantic salmon. Furthermore, and to heed off any criticism that they could breed with and destroy natural salmon, these genetically engineered fish will be sterile, exclusively female and grown in landlocked pools. This salmon could be the first GM animal to hit the dinner table. That is stunning news for diners, for farmers, for all those concerned with feeding the world's population and for biotechnology. I strongly believe there are huge profits to be made in biotechnology. It is a topic I have become fascinated with in the last couple of years. That's why I am going to offer you a unique chance of exploiting this booming industry with me. Very soon I'll show you where you could make huge profits in this rapidly growing industry. I'll be sending you details of how you can join me on this journey in the coming month or so. Stay tuned. Good investing, Tom Bulford The Penny Sleuth |
Posted at 07/1/2013 09:47 by lufc5 Here we go guys...shows how tightly this is held...they couldn't even get that 2.5%. Great news imo.7 January 2013 AquaBounty Technologies, Inc. ("AquaBounty" or "the Company") Update on Proposed Tender Offer by Intrexon Further to the announcement of 5 December 2012, AquaBounty Technologies, Inc. (AIM: ABTX), a biotechnology company focused on enhancing productivity in the aquaculture market, provides an update on the tender offer ("the Offer") by Intrexon Corporation ("Intrexon"), a privately held biotechnology company, to shareholders to purchase the issued and outstanding share capital of the Company not owned by Intrexon. In accordance with the terms of AquaBounty's Certificate of Incorporation, the Offer was conditional on receiving acceptances in respect of shares that, together with Intrexon's holding of 47.56%, will result in Intrexon holding shares constituting more than 50% of the issued and outstanding shares of AquaBounty common stock. The acceptances combined with Intrexon's current holding did not meet this threshold. As such, the conditions of the Offer have not been met and Intrexon will not acquire the common shares tendered in the Offer. Those AquaBounty shareholders who accepted the Offer and tendered their shares will have returned to them their relevant share certificates and other documents of title in accordance with the terms of the Offer. As stated in the Offer document, pursuant to the terms of the Relationship Agreement, Intrexon has the right, based on its current ownership, to appoint three of the six directors to AquaBounty's board of directors (the "Board"). When the nomination process has concluded, AquaBounty will announce to the market the Intrexon designees to the Board. |
Posted at 27/12/2012 07:59 by xcap LT shareholders having been waiting for this day for 2 year + can't see then voting through Interxon's offer price and Intrexon achieving 75% timing is excellent for the BoD to do a small capital raise to see them through 2013. if share price gets to 50p , £2m = 4m shares miminal dilution |
Posted at 26/12/2012 23:24 by johnwalton interesting stuff but one of the rnss stated that they have borrowed 500kand I think that they may go for cash if the share price keeps rising. perhaps a share issue. |
Posted at 31/10/2012 18:25 by lufc5 31 October 2012AquaBounty Technologies, Inc. ("AquaBounty" or "the Company") Change in Shareholding and Proposed Offer AquaBounty Technologies, Inc. (AIM: ABTX), a biotechnology company focused on enhancing productivity in the aquaculture market, announces that Linnaeus Capital Partners, B.V. ("Linnaeus") and its subsidiary Tethys Ocean, B.V. ("Tethys"), together the largest shareholders in the Company, have agreed to sell their combined shareholdings to Intrexon Corporation ("Intrexon"), a privately held biotechnology company. Intrexon has agreed to purchase 48,631,444 common shares (47.65 % of the current issued share capital of the Company), representing the entire shareholding of Linnaeus and Tethys, for $6.0 million or 12.3 cents (7.64 pence) per share. The acquisition price represents a premium of 49% to the closing price of 5.12 pence per AquaBounty common share on 31 October 2012, being the last business day prior to the acquisition of the shares. Following the close of this transaction, Linnaeus and Tethys will have no interest in AquaBounty shares and their four Directors on the Company's Board will resign their seats. AquaBounty's Certificate of Incorporation requires any person that acquires securities representing 30% or more of its voting power to make a cash offer for the remaining issued and outstanding capital stock of the Company at the highest price that person has paid in the preceding 12 months. Therefore, Intrexon has informed the Board that it will make an offer ("the Offer") to all other shareholders at the same price per share for the issued and outstanding share capital of the Company not owned by them. The Company is in discussion with Intrexon about the next steps and shareholders can expect to receive a circular from the Board with its recommended course of action. A further announcement outlining the details of the Offer will be made at the earliest available opportunity. Intrexon and AquaBounty have executed an agreement restricting certain activities of the Company prior to, and during, the tender offer. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
